In terms of antitumour capacity, NK cell-derived IFN-γ can inhibit tumorigenesis and reduce tumour burden by inhibiting angiogenesis [36], increasing fibronectin expression [37], inducing tumour-specific T cell responses [38], and so on. This evidence concerns the gene IFNG and neoplasm.